SMT201600083B - Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi - Google Patents

Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi

Info

Publication number
SMT201600083B
SMT201600083B SM201600083T SM201600083T SMT201600083B SM T201600083 B SMT201600083 B SM T201600083B SM 201600083 T SM201600083 T SM 201600083T SM 201600083 T SM201600083 T SM 201600083T SM T201600083 B SMT201600083 B SM T201600083B
Authority
SM
San Marino
Prior art keywords
synthasis
diidropirrol
aromatasis
aldosterone
imidazolyl
Prior art date
Application number
SM201600083T
Other languages
English (en)
Italian (it)
Inventor
Paul Sutton
Eric Loeser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600083(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SMT201600083B publication Critical patent/SMT201600083B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SM201600083T 2012-01-17 2016-03-23 Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi SMT201600083B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17
PCT/US2013/021521 WO2013109514A1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (1)

Publication Number Publication Date
SMT201600083B true SMT201600083B (it) 2016-04-29

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600083T SMT201600083B (it) 2012-01-17 2016-03-23 Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi

Country Status (40)

Country Link
US (2) US9334276B2 (cs)
EP (1) EP2804863B1 (cs)
JP (1) JP5749410B2 (cs)
KR (2) KR20140093726A (cs)
CN (1) CN104039793B (cs)
AP (1) AP2014007762A0 (cs)
AR (1) AR089728A1 (cs)
AU (1) AU2013209952B2 (cs)
BR (1) BR112014017260A8 (cs)
CA (1) CA2863339C (cs)
CL (1) CL2014001863A1 (cs)
CO (1) CO7000775A2 (cs)
CR (1) CR20140345A (cs)
CU (1) CU20140086A7 (cs)
CY (1) CY1117914T1 (cs)
DK (1) DK2804863T3 (cs)
EA (1) EA026232B1 (cs)
ES (1) ES2564143T3 (cs)
GT (1) GT201400155A (cs)
HR (1) HRP20160178T1 (cs)
HU (1) HUE026984T2 (cs)
IL (1) IL233541B (cs)
IN (1) IN2014DN06781A (cs)
JO (1) JO3137B1 (cs)
MA (1) MA35858B1 (cs)
MX (1) MX2014008686A (cs)
NZ (1) NZ626277A (cs)
PE (1) PE20142358A1 (cs)
PH (1) PH12014501638A1 (cs)
PL (1) PL2804863T3 (cs)
RS (1) RS54589B1 (cs)
SG (1) SG11201404061YA (cs)
SI (1) SI2804863T1 (cs)
SM (1) SMT201600083B (cs)
TN (1) TN2014000256A1 (cs)
TW (1) TWI609869B (cs)
UA (1) UA114803C2 (cs)
UY (1) UY34576A (cs)
WO (1) WO2013109514A1 (cs)
ZA (1) ZA201404314B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2598708C2 (ru) * 2010-01-14 2016-09-27 Новартис Аг Применение агента, обладающего модифицирующими свойствами в отношении гормонов надпочечников
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
SG11201610227TA (en) * 2014-07-07 2017-01-27 Novartis Ag Pharmaceutical dosage forms
US10556869B2 (en) 2015-01-29 2020-02-11 Novartis Ag Process for the production of condensed imidazolo derivatives
US20160287565A1 (en) * 2015-04-06 2016-10-06 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
US10822332B2 (en) 2016-10-27 2020-11-03 Damian Pharma Ag Aldosterone synthase inhibitor
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
BR112020022173A2 (pt) 2018-05-03 2021-02-02 Damian Pharma Ag r-fadrozol para uso no tratamento de aldostonerismo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) * 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
DK0625155T3 (da) 1992-01-27 2001-11-12 Janssen Pharmaceutica Nv Pyrroloimidazolyl- og imidazopyridinyl-substituerede 1H-benzimidazolderivater som aromataseinhibitorer
ES2305520T3 (es) * 2002-11-18 2008-11-01 Novartis Ag Derivados de imidazo(1,5a)piridina y metodos para tratar enfermedades mediadas por aldosterona.
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
KR20090094374A (ko) 2006-12-18 2009-09-04 노파르티스 아게 1-치환된 이미다졸 유도체 및 알도스테론 신타제 억제제로서의 그의 용도
WO2011064376A1 (en) 2009-11-30 2011-06-03 Novartis Ag Imidazole derivatives as aldosterone synthase inhibitors
RU2598708C2 (ru) * 2010-01-14 2016-09-27 Новартис Аг Применение агента, обладающего модифицирующими свойствами в отношении гормонов надпочечников

Also Published As

Publication number Publication date
CL2014001863A1 (es) 2014-11-07
UA114803C2 (uk) 2017-08-10
TN2014000256A1 (en) 2015-09-30
MA35858B1 (fr) 2014-12-01
EA026232B1 (ru) 2017-03-31
JO3137B1 (ar) 2017-09-20
AP2014007762A0 (en) 2014-07-31
NZ626277A (en) 2015-10-30
JP2015503627A (ja) 2015-02-02
ES2564143T3 (es) 2016-03-18
IL233541B (en) 2018-12-31
ES2564143T8 (es) 2020-11-18
AU2013209952B2 (en) 2016-09-01
HRP20160178T1 (hr) 2016-03-25
CN104039793B (zh) 2017-05-10
JP5749410B2 (ja) 2015-07-15
HK1198536A1 (en) 2015-05-15
CA2863339C (en) 2021-03-23
IN2014DN06781A (cs) 2015-05-22
TWI609869B (zh) 2018-01-01
EP2804863A1 (en) 2014-11-26
CY1117914T1 (el) 2017-05-17
US9334276B2 (en) 2016-05-10
US20140364470A1 (en) 2014-12-11
DK2804863T3 (en) 2016-03-07
SG11201404061YA (en) 2014-08-28
SI2804863T1 (sl) 2016-05-31
CU20140086A7 (es) 2014-12-26
PL2804863T3 (pl) 2016-06-30
AU2013209952A1 (en) 2014-07-24
US20160176883A1 (en) 2016-06-23
CR20140345A (es) 2014-09-09
IL233541A0 (en) 2014-08-31
AR089728A1 (es) 2014-09-10
PH12014501638B1 (en) 2014-10-13
PE20142358A1 (es) 2015-01-30
KR20140093726A (ko) 2014-07-28
HUE026984T2 (en) 2016-08-29
WO2013109514A1 (en) 2013-07-25
BR112014017260A8 (pt) 2017-07-04
EA201491374A1 (ru) 2014-12-30
PH12014501638A1 (en) 2014-10-13
MX2014008686A (es) 2014-08-27
KR20140141687A (ko) 2014-12-10
CO7000775A2 (es) 2014-07-21
EP2804863B1 (en) 2015-12-02
ZA201404314B (en) 2015-08-26
RS54589B1 (sr) 2016-08-31
TW201335161A (zh) 2013-09-01
UY34576A (es) 2013-09-02
CN104039793A (zh) 2014-09-10
CA2863339A1 (en) 2013-07-25
GT201400155A (es) 2017-09-28
BR112014017260A2 (pt) 2017-06-13

Similar Documents

Publication Publication Date Title
FR22C1030I2 (fr) Formes cristallines d'un inhibiteur de la prolyle hydroxylase
SMT201600083B (it) Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi
SMT201600311B (it) Inibitori di cdk
SMT201700052B (it) 2-(azaindol-2-il)benzimidazoli come inibitori di pad4
CR20120576A (es) Inhibidores de pirazolil quinazolina cinasa
SMT201600141B (it) Boronati quali inibitori di arginasi
EP2710007A4 (en) Kinase inhibitors
CO6970602A2 (es) Inhibidores de quinasa
SMT201500291B (it) Nuovi agenti antimalarici
HRP20151310T1 (xx) Spojevi piridazinona i njihova uporaba kao inhibitori daao
BR112013025761A2 (pt) inibidores de hsp90
SI3070091T1 (sl) Derivati benzodioksola kot zaviralci fosfodiesteraze
EP2623763A4 (en) Cylinder head
EP2933248A4 (en) NOVEL RENIN INHIBITOR
IL233712A0 (en) Sulfonamide derivatives used as mogat–2 inhibitors
BR112013030341A2 (pt) inibidores de glutaminil ciclase radiomarcados
BR112013014148A2 (pt) inibidores de corrosão
EP2629616A4 (en) SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER
EP2753623A4 (en) GAMMASEKRETASEHEMMER
EP2694057A4 (en) LIPOXYGENASE INHIBITORS
BR112013010699A2 (pt) derivados de pirrolidina usados como inibidores de catepsina
BR112013014484A2 (pt) compostos inibidores de metaloenzimas
EP2861071A4 (en) ALDOSTERONSYNTHASEHEMMER
BR112013018329A2 (pt) ferramenta de perfilagem
IL227814A0 (en) Cathepsin c inhibitors